tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Paradigm Biopharmaceuticals Director Acquires New Options
Company AnnouncementsParadigm Biopharmaceuticals Director Acquires New Options
8d ago
Paradigm Biopharmaceuticals Announces Director’s Securities Interest Update
PremiumCompany Announcements
Paradigm Biopharmaceuticals Announces Director’s Securities Interest Update
8d ago
Paradigm Biopharmaceuticals Issues New Securities to Bolster Strategic Initiatives
PremiumCompany Announcements
Paradigm Biopharmaceuticals Issues New Securities to Bolster Strategic Initiatives
12d ago
Paradigm Biopharmaceuticals Amends Bonus Issue Announcement
PremiumCompany Announcements
Paradigm Biopharmaceuticals Amends Bonus Issue Announcement
20d ago
Paradigm Biopharmaceuticals Announces Strategic Bonus Issue of Securities
PremiumCompany Announcements
Paradigm Biopharmaceuticals Announces Strategic Bonus Issue of Securities
22d ago
Paradigm Biopharmaceuticals Unveils Shareholder Reward Program with Potential $111M Fundraising
PremiumCompany AnnouncementsParadigm Biopharmaceuticals Unveils Shareholder Reward Program with Potential $111M Fundraising
22d ago
Paradigm Biopharmaceuticals Advances Phase 3 Trials with Strong Financial Backing
Premium
Company Announcements
Paradigm Biopharmaceuticals Advances Phase 3 Trials with Strong Financial Backing
23d ago
Paradigm Biopharmaceuticals Announces ASX Quotation of Securities
Premium
Company Announcements
Paradigm Biopharmaceuticals Announces ASX Quotation of Securities
24d ago
Paradigm Biopharmaceuticals Strengthens Financial Position with R&D Tax Incentive
PremiumCompany Announcements
Paradigm Biopharmaceuticals Strengthens Financial Position with R&D Tax Incentive
30d ago
Paradigm Biopharmaceuticals to Release Escrowed Securities from Employee Share Plan
PremiumCompany Announcements
Paradigm Biopharmaceuticals to Release Escrowed Securities from Employee Share Plan
1M ago
Paradigm Biopharmaceuticals Updates on Director’s Securities
PremiumCompany Announcements
Paradigm Biopharmaceuticals Updates on Director’s Securities
2M ago
Paradigm Biopharmaceuticals Issues New Performance Rights
PremiumCompany Announcements
Paradigm Biopharmaceuticals Issues New Performance Rights
2M ago
Paradigm Biopharmaceuticals Issues New Shares Amid Drug Development Focus
PremiumCompany AnnouncementsParadigm Biopharmaceuticals Issues New Shares Amid Drug Development Focus
2M ago
Paradigm Biopharma Highlights Investment Risks and Cautions
Premium
Company Announcements
Paradigm Biopharma Highlights Investment Risks and Cautions
3M ago
Paradigm Biopharmaceuticals Secures $16M for Global Trials
Premium
Company Announcements
Paradigm Biopharmaceuticals Secures $16M for Global Trials
3M ago
Paradigm Biopharmaceuticals Director Alters Investment Strategy
PremiumCompany Announcements
Paradigm Biopharmaceuticals Director Alters Investment Strategy
3M ago
Paradigm Biopharmaceuticals Expands with New Security Issuance
PremiumCompany Announcements
Paradigm Biopharmaceuticals Expands with New Security Issuance
3M ago
Paradigm Biopharmaceuticals Advances Knee OA Trial
PremiumCompany Announcements
Paradigm Biopharmaceuticals Advances Knee OA Trial
3M ago
Paradigm Biopharmaceuticals Sees Stock Surge Amid Clinical Trials
PremiumCompany Announcements
Paradigm Biopharmaceuticals Sees Stock Surge Amid Clinical Trials
3M ago
Paradigm Biopharmaceuticals: Director’s Shareholding Update
PremiumCompany AnnouncementsParadigm Biopharmaceuticals: Director’s Shareholding Update
3M ago
Paradigm Biopharmaceuticals Shifts Leadership Focus with Dr. Skerrett
Premium
Company Announcements
Paradigm Biopharmaceuticals Shifts Leadership Focus with Dr. Skerrett
3M ago
Paradigm Biopharmaceuticals Advances with Key Resolutions
Premium
Company Announcements
Paradigm Biopharmaceuticals Advances with Key Resolutions
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >